India’s Hetero pulls heart drug from U.S. amid cancer risk probes

0
3
Peru president expects lithium, uranium mining laws passed in 6 months



A unit of India’s Hetero Drugs is
recalling some batches of the blood pressure and heart medicine
valsartan in the United States, a notice on the U.S. regulator’s
website said, amid a wider probe into cancer risks associated
with the drug.

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here